Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

17.05

-0.14 (-0.81%)

At close: Apr 15, 2025, 4:00 PM

16.02

-1.03 (-6.04%)

Pre-market: Apr 16, 2025, 4:26 AM EDT

Enliven Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	836	1,099	570	-	-	-
Market Cap Growth	92.74%	92.74%	-	-	-	-
Enterprise Value	522	808	307	-	-	-
Last Close Price	17.05	22.50	13.84	-	-	-
PB Ratio	2.69	3.55	2.32	-	-	-
P/TBV Ratio	2.70	3.55	2.32	-	-	-
Debt / Equity Ratio	-	-	0.00	0.01	0.00	0.00
Quick Ratio	19.70	19.70	9.78	7.78	19.13	88.20
Current Ratio	19.99	19.99	10.28	8.00	19.24	88.35
Return on Equity (ROE)	-32.04%	-32.04%	-44.90%	-41.90%	-20.94%	-
Return on Assets (ROA)	-21.87%	-21.87%	-28.94%	-24.66%	-12.67%	-
Return on Capital (ROIC)	-23.50%	-23.50%	-32.14%	-26.86%	-13.08%	-
Earnings Yield	-1065.48%	-8.10%	-12.55%	-	-	-
FCF Yield	-876.53%	-6.66%	-10.77%	-	-	-
Buyback Yield / Dilution	-3242.60%	-32.43%	-1037.74%	60.02%	-56.70%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q